Literature DB >> 24882714

Protein fingerprint of colorectal cancer, adenomatous polyps, and normal mucosa using ProteinChip analysis on laser capture microdissected cells.

Wenhong Xu1, Yiding Chen, Wenqian He, Zhixuan Fu, Tao Pan, Hong He, Jiekai Yu, Qichun Wei, Shu Zheng, Suzhan Zhang.   

Abstract

To find new biomarkers and establish histopathology protein fingerprint models for early detection of colorectal cancer (CRC), laser capture microdissection (LCM) was utilized to obtain 3 groups of cells of interest--CRC tissues, their adjacent normal colorectal tissues, and their adjacent adenomatous polyps tissues--from the same 12 CRC patients. Each sample was then detected by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology and CM10 protein chip as well as bioinformatics tools. Model 1 formed by 15 protein peaks could be used to distinguish CRC tissues from normal tissues. The diagnostic pattern constructed using support vector machine (SVM) including the 15 proteins showed maximum Youden index (YI). Model 2 formed by 14 protein peaks could be used to distinguish CRC tissues from adenomatous polyps tissues. The two patterns were validated and the results showed that the sensitivity and specificity were both 100.0%. Model 3 formed by 15 protein peaks could distinguish adenomatous polyps tissues from normal tissues with a sensitivity of 92.3% and specificity of 100.0%. The protein peaks m/z 3570 and 5224 were identified in screening for changes during cancer progression. Peak 5224 was significantly upregulated in CRC. However, peak 3570 was significantly downregulated in CRC. LCM technology coupled with SELDI protein chip and bioinformatics approaches could effectively screen the differentially expressed protein profiles and establish molecular diagnosis models with high sensitivity and specificity for CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24882714

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  2 in total

1.  Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphoma.

Authors:  Wenhong Xu; Yue Hu; Xuexin He; Jun Li; Tao Pan; Hai Liu; Xianguo Wu; Hong He; Weiting Ge; Jiekai Yu; Qichun Wei; Shu Zheng; Suzhan Zhang; Yiding Chen
Journal:  Tumour Biol       Date:  2014-11-20

2.  TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors.

Authors:  Marleen M Nieboer; Lambert C J Dorssers; Roy Straver; Leendert H J Looijenga; Jeroen de Ridder
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.